Feng Li

Feng Li, Ph.D., is an Associate Professor at Baylor College of Medicine, affiliated with the Department of Pathology & Immunology and the Department of Pharmacology and Chemical Biology. He is also a member of the Center for Drug Discovery.

His research focuses on LC-MS-based metabolomics, drug metabolism and pharmacokinetics, drug-induced liver injury, and blood-testis barrier dynamics. Dr. Li has secured NIH funding for projects such as investigating duloxetine-induced liver toxicity and studying drug permeability across biological barriers.

Key research tools include MALDI imaging mass spectrometry and metabolomic approaches to analyze drug metabolites. His work bridges basic pharmacology with clinical applications in drug safety and development.

Selected grants include R01DK121970 (NIH/NIDDK) and R33HD099995 (NIH/NICHD).